Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Sloan Kettering Inst Can Research
New York, New York
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 92
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Robert Benezra | Conflict of Interest | AngioGenex, Inc. | >$600,000 | 2019 |
| Naiyer Rizvi | Conflict of Interest | Gritstone Oncology | >$600,000 | 2019 |
| Naiyer Rizvi | Conflict of Interest | Gritstone Oncology | >$600,000 | 2019 |
| Nai-Kong Cheung | Conflict of Interest | Y-mAbs Therapeutics | >$600,000 | 2019 |
| Renier Brentjens | Conflict of Interest | Juno Therapeutics | >$600,000 | 2016 |
| David Scheinberg | Conflict of Interest | Novartis | $400,000 - $449,999 | 2015 |
| Tao Dao | Conflict of Interest | Novartis | $400,000 - $449,999 | 2015 |
| Tao Dao | Conflict of Interest | Novartis | $400,000 - $449,999 | 2015 |
| David Scheinberg | Conflict of Interest | Novartis | $400,000 - $449,999 | 2015 |
| Timothy Chan | Conflict of Interest | Gritstone Oncology | $350,000 - $399,999 | 2019 |
| Timothy Chan | Conflict of Interest | Gritstone Oncology | $350,000 - $399,999 | 2019 |
| Timothy Chan | Conflict of Interest | Gritstone Oncology | $350,000 - $399,999 | 2019 |
| Sohrab Shah | Conflict of Interest | Contextual Genomics, Inc. | $300,000 - $349,999 | 2018 |
| C. David Allis | Conflict of Interest | Constellation Pharmaceuticals | $150,000 - $199,999 | 2013 |
| Andrew Vickers | Conflict of Interest | Arctic Partners | $150,000 - $199,999 | 2018 |
| Frederic Geissmann | Conflict of Interest | Neuroinflammation NewCo, Inc. | $60,000 - $79,999 | 2018 |
| Sohrab Shah | Conflict of Interest | Contextual Genomics, Inc. | $60,000 - $79,999 | 2018 |
| Charles Sawyers | Conflict of Interest | ORIC Pharmaceuticals | $60,000 - $79,999 | 2018 |
| Renier Brentjens | Conflict of Interest | Juno Therapeutics | $60,000 - $79,999 | 2016 |
| Charles Sawyers | Conflict of Interest | ORIC Pharmaceuticals | $60,000 - $79,999 | 2018 |
| David Scheinberg | Conflict of Interest | Sellas Life Sciences Group | $40,000 - $59,999 | 2018 |
| Marcel van Den Brink | Conflict of Interest | Seres Therapeutics | $20,000 - $39,999 | 2018 |
| Robert Benezra | Conflict of Interest | AngioGenex, Inc. | $20,000 - $39,999 | 2019 |
| Charles Rudin | Conflict of Interest | AbbVie Inc. | $10,000 - $19,999 | 2019 |
| Jedd Wolchok | Conflict of Interest | SELLAS Life Sciences Group, Inc | $10,000 - $19,999 | 2018 |
| Hans Lilja | Conflict of Interest | OPKO Health | $10,000 - $19,999 | 2017 |
| Laurence Rahme | Conflict of Interest | Spero Therapeutics, Inc. | $10,000 - $19,999 | 2014 |
| Naiyer Rizvi | Conflict of Interest | Personal Genome Diagnostics | $10,000 - $19,999 | 2019 |
| C. David Allis | Conflict of Interest | Constellation Pharmaceuticals | $10,000 - $19,999 | 2013 |
| Luke Dow | Conflict of Interest | Mirimus | $10,000 - $19,999 | 2017 |
| Robert Jenq | Conflict of Interest | Seres Therapeutics | $10,000 - $19,999 | 2016 |
| C. David Allis | Conflict of Interest | EMP Millipore | $10,000 - $19,999 | 2013 |
| Thomas Reiner | Conflict of Interest | Theragnostics, Ltd | $10,000 - $19,999 | 2019 |
| Allan Halpern | Conflict of Interest | Caliber ID | $5,000 - $9,999 | 2018 |
| Jedd Wolchok | Conflict of Interest | Bristol-Myers Squibb | $5,000 - $9,999 | 2018 |
| Timothy Chan | Conflict of Interest | Personal Genome Diagnostics | $5,000 - $9,999 | 2019 |
| Michelle Bradbury | Conflict of Interest | Claymore Nanotechnologies LLC | $0 - $4,999 | 2013 |
| Michelle Bradbury | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 | 2017 |
| Robert Jenq | Conflict of Interest | Epiva Therapeutics | $0 - $4,999 | 2015 |
| Michelle Bradbury | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 | 2017 |
| Michelle Bradbury | Conflict of Interest | Claymore Technologies, Inc. | $0 - $4,999 | 2015 |
| Ulrish Wiesner | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 | 2017 |
| Eric Pamer | Conflict of Interest | Epiva Therapeutics | $0 - $4,999 | 2015 |
| Jason Lewis | Conflict of Interest | Samus Therapeutics | $0 - $4,999 | 2013 |
| Gabriela Chiosis | Conflict of Interest | Samus Therapeutics | $0 - $4,999 | 2013 |
| Steven Larson | Conflict of Interest | Samus Therapeutics | $0 - $4,999 | 2013 |
| Robert Jenq | Conflict of Interest | Seres Therapeutics | $0 - $4,999 | 2016 |
| Robert Benerza | Conflict of Interest | AngioGenex | $0 - $4,999 | 2014 |
| Steven Larson | Conflict of Interest | Claymore Nanotechnologies LLC | $0 - $4,999 | 2013 |
| Eric Pamer | Conflict of Interest | Seres Therapeutics | $0 - $4,999 | 2016 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.